How to Image Cardiac Amyloidosis A Practical Approach

被引：164

作者：

Dorbala, Sharmila ^{[1
,2
,3
]}

Cuddy, Sarah ^{[1
,2
,3
]}

Falk, Rodney H. ^{[3
]}

机构：

[1] Brigham & Womens Hosp, Dept Radiol, Div Nucl Med, 75 Francis St, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Cardiovasc Div, CV Imaging Program, 75 Francis St, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Med, Div Cardiol, Cardiac Amyloidosis Program, Boston, MA USA

来源：

JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 06期

基金：

美国国家卫生研究院;

关键词：

amyloid tracers; cardiac amyloidosis; cardiac magnetic resonance; CMR; echocardiography; imaging; multimodality; radionuclide imaging; PET; pyrophosphate; Tc-99m-PYP; AL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; MAGNETIC-RESONANCE; HEART-FAILURE; MICROVASCULAR DYSFUNCTION; LIGHT-CHAINS; TRANSTHYRETIN; DIAGNOSIS; CMR; QUANTIFICATION;

D O I：

10.1016/j.jcmg.2019.07.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for light chain amyloidosis to 3 to 5 years for transthyretin amyloidosis. Early diagnosis and accurate typing of CA are necessary for optimal management of these patients. Emerging novel disease modifying therapies increase the urgency to diagnose CA at an early stage and identify patients who may benefit from these life-saving therapies. The goal of this review is to provide a practical approach to echocardiography, cardiac magnetic resonance, and radionuclide imaging in patients with known or suspected CA. (c) 2020 by the American College of Cardiology Foundation.

引用

页码：1368 / 1383

页数：16

共 50 条

[21] Cardiac Computed Tomography for Amyloidosis
Small, Gary R.
Poulin, Anthony
Tavoosi, Anahita
Small, Toby D.
Crean, Andrew M.
Chow, Benjamin J. W.
CURRENT CARDIOVASCULAR IMAGING REPORTS, 2021, 14 (11)
[22] Tissue Characterization in Cardiac Amyloidosis
Musetti, Veronica
Greco, Francesco
Castiglione, Vincenzo
Aimo, Alberto
Palmieri, Cataldo
Genovesi, Dario
Giorgetti, Assuero
Emdin, Michele
Vergaro, Giuseppe
McDonnell, Liam A.
Pucci, Angela
BIOMEDICINES, 2022, 10 (12)
[23] Advance of echocardiography in cardiac amyloidosis
Liang, Shichu
Liu, Zhiyue
Li, Qian
He, Wenfeng
Huang, He
HEART FAILURE REVIEWS, 2023, 28 (06) : 1345 - 1356
[24] Advanced Imaging in Cardiac Amyloidosis
Waldmeier, Dominik
Herzberg, Jan
Stephan, Frank-Peter
Seemann, Marcus
Arenja, Nisha
BIOMEDICINES, 2022, 10 (04)
[25] Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
Bistola, Vasiliki
Parissis, John
Foukarakis, Emmanouil
Valsamaki, Pipitsa N.
Anastasakis, Aris
Koutsis, Georgios
Efthimiadis, Georgios
Kastritis, Efstathios
HEART FAILURE REVIEWS, 2021, 26 (04) : 861 - 879
[26] Multi-modality imaging of cardiac amyloidosis: Contemporary update
Wang, Tom Kai Ming
Abou Hassan, Ossama K.
Jaber, Wael
Xu, Bo
WORLD JOURNAL OF RADIOLOGY, 2020, 12 (06): : 87 - 100
[27] Cardiac Amyloidosis: the Importance of a Multidisciplinary Approach
Gomez-Bueno, Manuel
Segovia, Javier
Garcia-Pavia, Pablo
Barcelo, Juan M.
Krsnik, Isabel
Sanchez-Turrion, Victor
Salas, Clara
Alonso-Pulpon, Luis
REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (06): : 698 - 702
[28] Recent Advances in Positron Emission Tomography Radiotracers to Image Cardiac Amyloidosis
Pabon, Ardel J. Romero
Clerc, Olivier F.
Vijayakumar, Shilpa
Cuddy, Sarah A. M.
Dorbala, Sharmila
CURRENT CARDIOLOGY REPORTS, 2024, 26 (11) : 1153 - 1162
[29] Cardiac Amyloidosis How Its Epidemiology is Changing
Panichella, Giorgia
Aimo, Alberto
Vergaro, Giuseppe
Castiglione, Vincenzo
Arzilli, Chiara
Giannoni, Alberto
Merlo, Marco
Limongelli, Giuseppe
Emdin, Michele
HEART FAILURE CLINICS, 2025, 20 (03) : e1 - e10
[30] Cardiac amyloidosis: when to suspect and how to confirm
Emdin, Michele
Aimo, Alberto
Chen, Yu Fu Ferrari
Merlo, Marco
Porcari, Aldostefano
Vergaro, Giuseppe
Sinagra, Gianfranco
JOURNAL OF CARDIOVASCULAR MEDICINE, 2025, 26 (02) : 102 - 105

← 1 2 3 4 5 →